219 related articles for article (PubMed ID: 7917561)
1. [Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].
Villanueva C; Martínez FJ; Torras X; Sáinz S; Soriano G; González D; Balanzó J
Rev Esp Enferm Dig; 1994 Jul; 86(1):499-504. PubMed ID: 7917561
[TBL] [Abstract][Full Text] [Related]
2. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
de la Peña J; Brullet E; Sanchez-Hernández E; Rivero M; Vergara M; Martin-Lorente JL; Garcia Suárez C
Hepatology; 2005 Mar; 41(3):572-8. PubMed ID: 15726659
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.
Lo GH; Lai KH; Cheng JS; Chen MH; Huang HC; Hsu PI; Lin CK
Hepatology; 2000 Sep; 32(3):461-5. PubMed ID: 10960435
[TBL] [Abstract][Full Text] [Related]
4. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.
Masci E; Stigliano R; Mariani A; Bertoni G; Baroncini D; Cennamo V; Micheletti G; Casetti T; Tansini P; Buscarini E; Ranzato R; Norberto L
Hepatogastroenterology; 1999; 46(27):1769-73. PubMed ID: 10430341
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
[TBL] [Abstract][Full Text] [Related]
6. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices.
Krige JE; Kotze UK; Bornman PC; Shaw JM; Klipin M
Ann Surg; 2006 Nov; 244(5):764-70. PubMed ID: 17060770
[TBL] [Abstract][Full Text] [Related]
7. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis.
Zuberi BF; Baloch Q
Am J Gastroenterol; 2000 Mar; 95(3):768-71. PubMed ID: 10710072
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: a multicenter prospective randomized trial.
Saeed ZA; Stiegmann GV; Ramirez FC; Reveille RM; Goff JS; Hepps KS; Cole RA
Hepatology; 1997 Jan; 25(1):71-4. PubMed ID: 8985267
[TBL] [Abstract][Full Text] [Related]
9. Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial.
Djurdjevic D; Janosevic S; Dapcevic B; Vukcevic V; Djordjevic D; Svorcan P; Grgov S
Endoscopy; 1999 May; 31(4):286-90. PubMed ID: 10376453
[TBL] [Abstract][Full Text] [Related]
10. [Sclerotherapy of esophageal varices using ethanol in combination with propranolol: clinical study of 30 patients].
Poynard T; Aubert A; Naveau S; Lemman M; Chaput JC
Gastroenterol Clin Biol; 1988 Dec; 12(12):899-905. PubMed ID: 3069544
[TBL] [Abstract][Full Text] [Related]
11. Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk.
Huizinga WK; Angorn IB; Baker LW
Surg Gynecol Obstet; 1985 Jun; 160(6):539-46. PubMed ID: 3873713
[TBL] [Abstract][Full Text] [Related]
12. Improvement of tissue-adhesive obliteration of bleeding gastric varices using adjuvant hypertonic glucose injection: a prospective randomized trial.
Kuo MJ; Yeh HZ; Chen GH; Poon SK; Yang SS; Lien HC; Chang CS
Endoscopy; 2007 Jun; 39(6):487-91. PubMed ID: 17354182
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of recurrent hemorrhage in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy].
Martin T; Taupignon A; Lavignolle A; Perrin D; Le Bodic L
Gastroenterol Clin Biol; 1991; 15(11):833-7. PubMed ID: 1769473
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic sclerotherapy versus oesophageal transection in the prevention of variceal rebleeding.
Nos P; Sala T; Pertejo V; Berenguer M; Garrigues V; Pons V; Juan M; Berenguer J
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):231-5. PubMed ID: 7743305
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of 2 years' experience with elective endoscopic sclerotherapy of hemorrhagic esophageal varices in cirrhotic patients].
Bretagne JF; Morisot D; Gastard J
Gastroenterol Clin Biol; 1985 Nov; 9(11):809-13. PubMed ID: 3878811
[TBL] [Abstract][Full Text] [Related]
16. Long term survival and severe rebleeding after variceal sclerotherapy.
Balanzó J; Such J; Sainz S; González D; Guarner C; Allende L; Lacalle JP; Vilardell F
Surg Gynecol Obstet; 1990 Dec; 171(6):489-92. PubMed ID: 2244282
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopic sclerotherapy: a prospective randomized study.
Bhargava DK; Pokharna R
Am J Gastroenterol; 1997 Jun; 92(6):950-3. PubMed ID: 9177508
[TBL] [Abstract][Full Text] [Related]
18. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
[TBL] [Abstract][Full Text] [Related]
19. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: a prospective randomized study.
Garg PK; Joshi YK; Tandon RK
Gastrointest Endosc; 1999 Sep; 50(3):369-73. PubMed ID: 10462658
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
